Cargando…
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142063/ https://www.ncbi.nlm.nih.gov/pubmed/34031531 http://dx.doi.org/10.1038/s41375-021-01299-x |
| _version_ | 1783696499500122112 |
|---|---|
| author | Gritti, Giuseppe Raimondi, Federico Bottazzi, Barbara Ripamonti, Diego Riva, Ivano Landi, Francesco Alborghetti, Leonardo Frigeni, Marco Damiani, Marianna Micò, Caterina Fagiuoli, Stefano Lorini, Ferdinando Luca Gandini, Lucia Novelli, Luca Morgan, Jonathan P. Owens, Benjamin M. J. Kanhai, Karan J. K. Reljanovic, Gordana Tonkovic Rizzi, Marco Di Marco, Fabiano Mantovani, Alberto Rambaldi, Alessandro |
| author_facet | Gritti, Giuseppe Raimondi, Federico Bottazzi, Barbara Ripamonti, Diego Riva, Ivano Landi, Francesco Alborghetti, Leonardo Frigeni, Marco Damiani, Marianna Micò, Caterina Fagiuoli, Stefano Lorini, Ferdinando Luca Gandini, Lucia Novelli, Luca Morgan, Jonathan P. Owens, Benjamin M. J. Kanhai, Karan J. K. Reljanovic, Gordana Tonkovic Rizzi, Marco Di Marco, Fabiano Mantovani, Alberto Rambaldi, Alessandro |
| author_sort | Gritti, Giuseppe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8142063 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81420632021-05-24 Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 Gritti, Giuseppe Raimondi, Federico Bottazzi, Barbara Ripamonti, Diego Riva, Ivano Landi, Francesco Alborghetti, Leonardo Frigeni, Marco Damiani, Marianna Micò, Caterina Fagiuoli, Stefano Lorini, Ferdinando Luca Gandini, Lucia Novelli, Luca Morgan, Jonathan P. Owens, Benjamin M. J. Kanhai, Karan J. K. Reljanovic, Gordana Tonkovic Rizzi, Marco Di Marco, Fabiano Mantovani, Alberto Rambaldi, Alessandro Leukemia Letter Nature Publishing Group UK 2021-05-24 2021 /pmc/articles/PMC8142063/ /pubmed/34031531 http://dx.doi.org/10.1038/s41375-021-01299-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Gritti, Giuseppe Raimondi, Federico Bottazzi, Barbara Ripamonti, Diego Riva, Ivano Landi, Francesco Alborghetti, Leonardo Frigeni, Marco Damiani, Marianna Micò, Caterina Fagiuoli, Stefano Lorini, Ferdinando Luca Gandini, Lucia Novelli, Luca Morgan, Jonathan P. Owens, Benjamin M. J. Kanhai, Karan J. K. Reljanovic, Gordana Tonkovic Rizzi, Marco Di Marco, Fabiano Mantovani, Alberto Rambaldi, Alessandro Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title | Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title_full | Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title_fullStr | Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title_full_unstemmed | Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title_short | Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19 |
| title_sort | siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe covid-19 |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142063/ https://www.ncbi.nlm.nih.gov/pubmed/34031531 http://dx.doi.org/10.1038/s41375-021-01299-x |
| work_keys_str_mv | AT grittigiuseppe siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT raimondifederico siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT bottazzibarbara siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT ripamontidiego siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT rivaivano siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT landifrancesco siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT alborghettileonardo siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT frigenimarco siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT damianimarianna siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT micocaterina siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT fagiuolistefano siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT loriniferdinandoluca siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT gandinilucia siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT novelliluca siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT morganjonathanp siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT owensbenjaminmj siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT kanhaikaranjk siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT reljanovicgordanatonkovic siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT rizzimarco siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT dimarcofabiano siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT mantovanialberto siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 AT rambaldialessandro siltuximabdownregulatesinterleukin8andpentraxin3toimproveventilatorystatusandsurvivalinseverecovid19 |